Literature DB >> 29517628

TH1 and TH2 Cytokine Profiles as Predictors of Severity in Acute Pancreatitis.

Antonio Rodriguez-Nicolas, Alba Martínez-Chamorro, Pilar Jiménez, Ana M Matas-Cobos, Eduardo Redondo-Cerezo, Francisco Ruiz-Cabello.   

Abstract

OBJECTIVES: Acute pancreatitis (AP) is severe in up to 20% of patients, with a high mortality rate. Quantification of serum TH1 and TH2 cytokines may provide objective evidence to assess the severity of AP and predict its course.
METHODS: One hundred seventeen patients were studied, measuring serum concentrations of interleukin (IL)1β, IL2, IL4, IL5, IL6, IL10, IL12p70, IL13, IL18, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon (IFN) γ, and tumor necrosis factor (TNF) α.
RESULTS: Significant differences were found between patients with severe AP and those with mild or moderately severe AP in IFN-γ (P < 0.001), IL6 (P < 0.001), TNF-α (P = 0.002), GM-CSF (P < 0.001), IL4 (P = 0.002), IL1b (P = 0.017), and IL13 (P < 0.001) concentrations. Interferon-γ, IL6, and TNF-α were associated with severe AP, whereas GM-CSF, IL4, IL1b, and IL13 were associated with mild or moderately severe AP. The IL13/IFNγ ratio was significantly higher in patients with mild AP (P = 7.36 × 10).
CONCLUSIONS: A TH1 profile was associated with severe AP and a TH2 profile with mild or moderately severe AP. We report an IL13/IFNγ ratio of potential value to predict the prognosis in AP.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29517628     DOI: 10.1097/MPA.0000000000001006

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Butyrate ameliorates caerulein-induced acute pancreatitis and associated intestinal injury by tissue-specific mechanisms.

Authors:  Xiaohua Pan; Xin Fang; Fei Wang; Hongli Li; Wenying Niu; Wenjie Liang; Chengfei Wu; Jiahong Li; Xing Tu; Li-Long Pan; Jia Sun
Journal:  Br J Pharmacol       Date:  2019-12-08       Impact factor: 8.739

2.  Electroacupuncture Ameliorates Acute Pancreatitis: A Role for the Vagus Nerve-Mediated Cholinergic Anti-Inflammatory Pathway.

Authors:  Luyao Zhang; Zhiyang Wu; Jing Zhou; Shengfeng Lu; Chaofan Wang; Yiqiu Xia; Hongyan Ren; Zhihui Tong; Lu Ke; Weiqin Li
Journal:  Front Mol Biosci       Date:  2021-05-13

3.  Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis.

Authors:  Yan Zhang; Bo Cheng; Zhong-Wei Wu; Zong-Chao Cui; Yao-Dong Song; San-Yang Chen; Yan-Na Liu; Chang-Ju Zhu
Journal:  World J Gastroenterol       Date:  2021-10-14       Impact factor: 5.742

Review 4.  Innate Lymphoid Cells: Emerging Players in Pancreatic Disease.

Authors:  Saimeng Shi; Longyun Ye; Kaizhou Jin; Zhiwen Xiao; Xianjun Yu; Weiding Wu
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

5.  Sodium Butyrate Attenuates Taurocholate-Induced Acute Pancreatitis by Maintaining Colonic Barrier and Regulating Gut Microorganisms in Mice.

Authors:  Yangyang Xiong; Li Ji; Yi Zhao; Ailing Liu; Dong Wu; Jiaming Qian
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

6.  Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor-induced diabetes.

Authors:  Ana Luisa Perdigoto; Songyan Deng; Katherine C Du; Manik Kuchroo; Daniel B Burkhardt; Alexander Tong; Gary Israel; Marie E Robert; Stuart P Weisberg; Nancy Kirkiles-Smith; Angeliki M Stamatouli; Harriet M Kluger; Zoe Quandt; Arabella Young; Mei-Ling Yang; Mark J Mamula; Jordan S Pober; Mark S Anderson; Smita Krishnaswamy; Kevan C Herold
Journal:  JCI Insight       Date:  2022-09-08

Review 7.  Circulating Lymphocyte Subsets Induce Secondary Infection in Acute Pancreatitis.

Authors:  Lili Ding; Yimin Yang; Hongxiang Li; Haijiao Wang; Pujun Gao
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

Review 8.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.